Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abby Alpert

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Health Economics|July 4, 2016
The anticipatory effects of Medicare Part D on drug utilizationAbby Alpert
JAMA Health Forum|November 14, 2025
Assessing the Case Against Direct-to-Consumer Drug AdvertisementsAbby Alpert, Neeraj Sood
Clinical Pharmacology and Therapeutics|February 11, 2019
Impact of Oncology Drug Shortages on Chemotherapy TreatmentAbby Alpert, Mireille Jacobson
Health Affairs (Project Hope)|April 5, 2017
Evaluating The Role Of Payment Policy In Driving Vertical Integration In The Oncology MarketAbby Alpert, Helen Hsi, Mireille Jacobson
Journal of Public Economics|June 5, 2023
Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part DAbby Alpert, Darius Lakdawalla, Neeraj Sood
Health Affairs (Project Hope)|April 2, 2019
Abuse-Deterrent Opioids: The Authors ReplyDavid Powell, Abby Alpert, Rosalie L Pacula
American Economic Journal. Economic Policy|July 30, 2021
Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent OpioidsAbby Alpert, David Powell, Rosalie Liccardo Pacula
Health Affairs (Project Hope)|February 5, 2019
A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis CDavid Powell, Abby Alpert, Rosalie L Pacula
Journal of Health Economics|February 3, 2026
The impact of immunotherapy on reductions in cancer mortality: Evidence from MedicareDanea Horn, Abby Alpert, Mark Duggan, et al.
The Quarterly Journal of Economics|July 14, 2022
ORIGINS OF THE OPIOID CRISIS AND ITS ENDURING IMPACTSAbby Alpert, William N Evans, Ethan M J Lieber, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Health Economics|July 4, 2016
The anticipatory effects of Medicare Part D on drug utilizationAbby Alpert
JAMA Health Forum|November 14, 2025
Assessing the Case Against Direct-to-Consumer Drug AdvertisementsAbby Alpert, Neeraj Sood
Clinical Pharmacology and Therapeutics|February 11, 2019
Impact of Oncology Drug Shortages on Chemotherapy TreatmentAbby Alpert, Mireille Jacobson
Health Affairs (Project Hope)|April 5, 2017
Evaluating The Role Of Payment Policy In Driving Vertical Integration In The Oncology MarketAbby Alpert, Helen Hsi, Mireille Jacobson
Journal of Public Economics|June 5, 2023
Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part DAbby Alpert, Darius Lakdawalla, Neeraj Sood
Health Affairs (Project Hope)|April 2, 2019
Abuse-Deterrent Opioids: The Authors ReplyDavid Powell, Abby Alpert, Rosalie L Pacula
American Economic Journal. Economic Policy|July 30, 2021
Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent OpioidsAbby Alpert, David Powell, Rosalie Liccardo Pacula
Health Affairs (Project Hope)|February 5, 2019
A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis CDavid Powell, Abby Alpert, Rosalie L Pacula
Journal of Health Economics|February 3, 2026
The impact of immunotherapy on reductions in cancer mortality: Evidence from MedicareDanea Horn, Abby Alpert, Mark Duggan, et al.
The Quarterly Journal of Economics|July 14, 2022
ORIGINS OF THE OPIOID CRISIS AND ITS ENDURING IMPACTSAbby Alpert, William N Evans, Ethan M J Lieber, et al.
Pageof 2